All In Biotech

Drug Trial Radar · NCT01719653

A Comparison of 5 Low Volume Bowel Preparations

A Randomized Comparison of Five Low Volume Bowel Preparations for Colonoscopy

Last checked: Nov 19, 2026Latest source record: Mar 24, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 1,079 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,079

Actual

Start

Oct 2012

Primary completion

Sep 2014

Study completion Sep 2014

Sponsor

Lead sponsor
Gastroenterology Services, Ltd.Academic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 1, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this investigation is to compare 3 versions of MiraLAX/Gatorade, MoviPrep and SUPREP to see which preparation cleanses the colon best and which preparation is best tolerated.

Conditions

  • Bowel Preparation for Colonoscopy

Interventions

  • MiraLAXDrug

    MiraLAX consumed as described in each arm.

  • GatoradeOther

    Gatorade consumed as described in each arm.

  • MoviPrepDrug

    MoviPrep consumed as described in each arm.

  • SUPREPDrug

    SUPREP consumed as described in each arm.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Chicago Bowel Preparation ScaleTime frame: At completion of colonoscopy - day 1

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Gastroenterology Services

    Downers Grove, Illinois

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.